Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
British Journal of Haematology|March 15, 2023
Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group studySarah A Milgrom, Jihyun Kim, Qinglin Pei, et al.Molecular Imaging and Biology|April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Esther Mena, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumorsElizabeth Fox, John M Maris, Brigitte C Widemann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 TrialXin Tie, Changhee Lee, Scott B Perlman, et al.Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.Nature Biomedical Engineering|December 4, 2018
DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injuryDawei Jiang, Zhilei Ge, Hyung-Jun Im, et al.Cancer|September 11, 2020
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group studyJames I Geller, Joseph G Pressey, Malcolm A Smith, et al.Pediatric Blood & Cancer|July 10, 2021
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031Sarah A Milgrom, Jihyun Kim, Alin Chirindel, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 7, 2024
TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysisFereshteh Yousefirizi, Ivan S Klyuzhin, Joo Hyun O, et al.Cancer Chemotherapy and Pharmacology|January 15, 2013
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, Edwin M Posadas, et al.Pageof 9